Hi abdm
"Assuming his reference was relating to our JDA negotiating FMCG partner, we could also ask why an update for the other FMCG partners, and the Major US Pharma in multi-product discussions with OBJ was also omitted from this update?
Could it be that the Major U.S Pharma is our good friend "GSK"
During the quarter the relationship with GSK was expanded to include discussions with the "GSK Pharmaceutical groups" in the US
As always please D Y O R
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable